Boston Partners’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
AIM
Boston Partners's PTEN Position: Q2 2025 in Review
Boston Partners sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 78,193 shares — an estimated $643K sold.
Boston Partners first reported a position in PTEN in Q3 2023 and held it in 5 quarters. The position peaked at $24.8M in Q3 2023. 360 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.
- Boston Partners reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
- Boston Partners sold 78,193 Patterson-UTI shares in Q2 2025, an estimated $643K.
- Boston Partners first reported a position in Patterson-UTI in Q3 2023 and held it in 5 quarters.
- Boston Partners's Patterson-UTI position peaked at $24.8M in Q3 2023.
- 360 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.
Based on Boston Partners's 13F filing for Q2 2025, filed 7 Aug 2025.